Skip to main content
Book cover

Drug-Induced Liver Toxicity

  • Book
  • © 2018

Overview

  • Includes cutting-edge techniques for the study of DILI
  • Contains key implementation advice from the experts
  • Features detail essential for labs, from basic research through to clinical action

Part of the book series: Methods in Pharmacology and Toxicology (MIPT)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (31 protocols)

  1. Introduction

  2. In Silico and Modeling Approaches

  3. In Vitro Technologies

Keywords

About this book

This book provides a comprehensive view of the methodologies used for the study of liver toxicity encountered throughout the whole life cycle of a drug, from drug discovery, to clinical trial, post-marketing, and even clinical practice. Organized into six sections, the first section introduces the mechanisms contributing to drug-induced liver toxicity.  The second and third section explore in silico and in vitro approaches used to help mitigate hepatotoxicity liability at the early stages of drug development. The fourth section describes methodologies applied in regulatory processes, including preclinical studies, clinical trials, and post-marketing surveillance. The fifth section discusses clinical hepatotoxicity. Emerging technologies are examined in the final section. As a volume in the Methods in Pharmacology and Toxicology series, chapters include the kind of expert advice that will lead to optimal results. 

Authoritative and practical, Drug-InducedLiver Toxicity serves all those who aim to improve assessment and understanding of hepatotoxic potentials of new medications and marketed drugs.



Chapter 30 is open access under a CC BY 4.0 license via link.springer.com. 


Editors and Affiliations

  • Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, USA

    Minjun Chen

  • Drug Safety Research and Development, Pfizer Inc., Groton, USA

    Yvonne Will

Bibliographic Information

  • Book Title: Drug-Induced Liver Toxicity

  • Editors: Minjun Chen, Yvonne Will

  • Series Title: Methods in Pharmacology and Toxicology

  • DOI: https://doi.org/10.1007/978-1-4939-7677-5

  • Publisher: Humana New York, NY

  • eBook Packages: Springer Protocols

  • Copyright Information: Springer Science+Business Media, LLC, part of Springer Nature 2018

  • Hardcover ISBN: 978-1-4939-7676-8Published: 21 March 2018

  • Softcover ISBN: 978-1-4939-9256-0Published: 10 December 2019

  • eBook ISBN: 978-1-4939-7677-5Published: 21 March 2018

  • Series ISSN: 1557-2153

  • Series E-ISSN: 1940-6053

  • Edition Number: 1

  • Number of Pages: XX, 667

  • Number of Illustrations: 49 b/w illustrations, 70 illustrations in colour

  • Topics: Pharmacology/Toxicology

Publish with us